Your Cart
Loading

Cyclaniliprole Patent Landscape Analysis

On Sale
$500.00
Pay what you want: (minimum $500.00)
$
Added to cart

Cyclaniliprole is a diamide insecticide developed by Ishihara Sangyo Kaisha (ISK), commercialised through the CYCLAPRYN™ brand (and products such as Harvanta® / Verdepryn®).

The retained landscape covers 79 patent families across 33 consolidated owner groups. Two-active combination is the thickest protection layer (58 families), with single-active formulation providing additional constraint.

55 of the 79 retained families carry a grant or national pending reading. 46 families are held by China-based applicants; seven live families have a nominal term ending within five years. Position as at October 2026.

This 45-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.

You will get a PDF (1MB) file

Customer Reviews

There are no reviews yet.